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Comparison of DNA extraction from cervical cells collected in PreservCyt solution for the
amplification of Chlamydia trachomatis
Objective: The aim of this study was to compare and evaluate three methods of DNA extraction for the
amplification of Chlamydia trachomatis in uterine cervical samples collected in PreservCyt solution. ThinPrep is the
trade name for the slide preparation.
Methods: Thirty-eight samples collected in LCx buffer medium, which were identified as C. trachomatis infected
by ligase chain reaction (LCR), were selected for this study. DNA from the PreservCyt samples was extracted
by three methods: (i) QIAamp kit, (ii) boiling in Tris-EDTA buffer with Chelex purification, and (iii) Proteinase K
digestion with Chelex purification. Sample DNA was tested for the presence of C. trachomatis by PCR using
cryptic plasmid research (CTP) primers and major outer membrane protein research momp gene (MOMP) primers.
Real-time (LightCycler) PCR for relative C. trachomatis quantification following DNA extraction was performed
using primers (Hsp 60) for the 60 kDa heat-shock protein hsp60 gene.
Results: Amplification using CTP primers was the most successful with each of the extraction protocols. Boiling
in buffer was the least successful extraction method. QIAamp was the best extraction method, yielding the
most positives with both the CTP and MOMP primers. Proteinase K-Chelex extraction gave similar sensitivity
to QIAamp extraction with CTP primers but lower for MOMP primers.
Conclusions: The DNA extraction method must be carefully selected to ensure that larger PCR amplicons can
be successfully produced by PCR and to ensure high sensitivity of detection of C. trachomatis. In this study it was
found that the QIAamp extraction method followed by PCR with the CTP primers was the most successful
for amplification of C. trachomatis DNA.
Keywords: DNA extraction, cervical cells, PreservCyt, Chlamydia trachomatis, PCR, LightCycler
Introduction
Gynaecological cytology is rapidly changing due to the
development of new technologies for smear prepar-
ation, automated evaluation and molecular analysis of
cervical smear samples.1,2
Liquid-based cervical smear preparation is over-
taking conventional smear preparation as the method
of choice for cytological evaluation due to the
improvement in rates of detection of preneoplastic
lesions, ease of slide interpretation and decrease in
number of unsatisfactory (repeat) smears.3,4 These
liquid-based cervical samples are rich in cellular
material, with thousands of residual cells remaining
in the solution after the preparation of a monolayer
smear. This cellular material is ideal for molecular
analysis of both host cell genome and for detection
and quantification of micro-organisms,5–7 thus offer-
ing the possibility of additional molecular tests for
patients who have abnormal epithelial cells or fea-
tures of inflammation on routine cytology.
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Detection of human papillomavirus in cervical
samples has been exhaustively studied in both con-
ventional and liquid-based cytology samples,8,9 how-
ever, detection and quantitation of Chlamydia
trachomatis has been less thoroughly explored.10,11
Chlamydia trachomatis is an obligate intracellular
bacterium which may be present in between 2%
and 17% of cervical smear samples from healthy
asymptomatic females depending on the population
studied.12 Infection with C. trachomatis may result in
pelvic inflammatory disease, infertility and is a major
cause of ectopic pregnancy. Numerous studies have
suggested that screening of young women for C.
trachomatis would be cost effective due to the ultimate
burden on the health service of the complications of
this infection.13–15
The main detection methods for C. trachomatis
include culture, enzyme immunoassay and nucleic
acid-based techniques (NAAT).16 Recent studies indi-
cate that the NAAT methods, which are mostly based
on PCR amplification of the C. trachomatis cryptic
plasmid sequences, offer the highest sensitivity for
detection of the organism.17,18 A hybrid capture (HC)
system has also been developed for Chlamydia detec-
tion, similar to the HCII system for HPV detection
(Digene Corporation).19
Methods for DNA extraction from cervical cells are
varied, mostly relying on some form of Proteinase K
extraction, with or without a further purification
step.20,21 Other protocols have been applied to cervical
cell samples, including simple boiling in buffer,
microwaving and automated DNA extraction tech-
niques.22,23 In this study three methods of DNA
extraction from uterine cervical cell samples collected
into PreservCyt solution were evaluated, by the
sensitivity of detection and relative quantitation of C.
trachomatis by molecular (PCR) amplification methods
compared to a gold standard of routine cervical
samples tested by LCR.
Methods
Study population and clinical specimens
Cervical samples were taken from women attending a
genitourinary medicine clinic at St James Hospital,
Dublin, Ireland, and placed in LCx transport medium
(LCx; Abbott Laboratories, Chicago, IL, USA). These
were tested for C. trachomatis using the Ligase Chain
Reaction assay (LCx; Abbott Laboratories). A second
cervical sample was taken on the same visit and placed
in a vial of PreservCyt medium and transported to the
cytology laboratory of the hospital where a cervical
smear was made. Specimens were then kept at room
temperature and the DNA was extracted within
6 weeks. The sample population in this study consis-
ted of 38 women who tested positive for C. trachomatis
by the LCx.
DNA extraction
Fifteen millilitres of PreservCyt specimen was vortexed
briefly and divided into three 5-ml aliquots. Thesewere
then centrifuged at 13000 g and the pellet was washed
twicewith TE buffer (10 mMTris, 1 mMEDTA, pH8.0)
and resuspended in a final volume of 200 ll TE buffer.
In extraction method A (TE-Chelex), the cell suspen-
sion was boiled for 10 minutes with 0.1% Chelex
solution (Sigma-Aldrich, St. Louis, MO, USA). In
method B (Proteinase K-Chelex), the cells were resus-
pended in 200 ll of cell lysis buffer (10 mM Tris-HCl,
400 mM NaCl, 2 mM Na2EDTA, pH 8.2), with 20 ll of
Proteinase K (20 mg/ml) and 0.5% sodium dodecyl
sulphate and incubated at 65 C for 2.5 hours. This was
then boiled for 20 minutes with 0.1% Chelex-100
solution. In method C (QIAamp), the QIAamp DNA
Mini Kit (Qiagen Ltd, Crawley, UK)was used according
to the manufacturer’s instructions. DNA was extracted
froma single sampleusing the three extractionmethods
within the same 48-hour period. Following DNA
extraction samples were stored at )20 C, until
required for PCR.
PCR amplification of C. trachomatis plasmid and omp gene
The following primer sets were used for detection of
C. trachomatis: a plasmid primer set (CTP)24 (201 bp),
and a primer set (MOMP)25 for the major outer
membrane protein gene (540 bp), (Table 1, Figure 1).
PCR was performed in 20 ll reaction volume, con-
taining 2 ll PCR buffer (Invitrogen Ltd, Renfrew, UK),
1.5 mMMgCl2 200 lM of each dNTP, 25 pmol of each
primer set, 1 U of Taq DNA polymerase (Invitrogen
Ltd) and 5 ll of DNA sample. The PCR reaction
mixture was performed in a Hybaid Omni-E thermal
cycler (Hybaid Ltd, Ashford, UK), with an initial
denaturation of 95 C for 5 minutes followed by 40
cycles of 95 C for 1 minute, 55 C for 1 minute and
72 C for 2 minutes. After 40 cycles, a further elon-
gation step was carried out at 72 C for 5 minutes. The
products were run on a 1% agarose gel containing
0.5 lg/ll ethidium bromide.
Comparison of DNA extraction methods 83
Cytopathology 2005, 16, 82–87 ª 2005 Blackwell Publishing Ltd
Real-time PCR detection and quantitation of
C. trachomatis DNA
Real-time PCR for detection and quantitation of
C. trachomatiswas performed on all DNA samples using
a primer set (Hsp 60)26 specific for the heat-shock
protein 60 gene (Table 1). An aliquot of 1 ll of each
sample was added to 9 ll of a reaction mixture
containing 3 mM MgCl2, 0.5 lM primers and 1 ll of
LC DNA FastSTART Master SYBR Green I enzyme mix
(Roche Biochemicals, Mannheim, Germany). Samples
were amplified on a LightCycler (Roche) under the
following cycle conditions: an initial 10 minutes at
95 C for activation of the FastSTART Taq DNA
polymerase, followed by 40 cycles of 5 seconds of
denaturation at 95 C, 10 seconds of annealing at
68 C, decreasing to 65 C at a rate of 1 C/cycle and
30 seconds of extension at 72 C. Data were obtained
after the extension period in the single acquisition
mode. The Hsp 60 PCR product was cloned into a pBSII
vector and serially diluted cloned copies were used to
create a standard curve (105 to 102 copies) for quan-
titation of chlamydial copy numbers. These standards
were run with each LightCycler run and a calculation
of C. trachomatis copy numbers was taken by the
machine at the crossing point of each sample during
the exponential phase of amplification. A melt curve
step was included to confirm the amplification. Sam-
ples which gave copy numbers outside the range of the
standards or whosemelt-temperature (Tm) was outside
those of the standards had their real-time PCR product
analysed by agarose gel electrophoresis. A sample was
positive if amplification of the 650 bp product occurred
during the amplification programme of 40 cycles.
Results
DNA isolated from the 38 LCx-positive samples by
the three extraction protocols was analysed for
C. trachomatis positivity by PCR and real-time PCR
and quantified using real-time PCR. A positive result
for either the CTP or the MOMP primer set was
determined by the presence of 201 bp product for the
CTP primer set and a 540-bp product for the MOMP
primer set on agarose gel electrophoresis. The Hsp
60 real-time PCR assay was positive if quantified
C. trachomatis copy numbers were inside the range of
the standards or if running of the product on an
agarose gel gave the required 650 bp product size. 5
TE-Chelex, 5 Proteinase K-Chelex, and 2 QIAamp
samples had copy numbers below the range of the
standards (<100) but were positive on gel electro-
phoresis of the PCR product.
Detection of C. trachomatis by plasmid, major outer
membrane protein and heat-shock protein 60 real-time PCR
Ninety-five percent (36/38) of samples extracted using
either the TE-Chelex method or the Proteinase
K-Chelex method were positive for C. trachomatis by
either of the three PCRs. The QIAamp samples gave a
slightly higher overall positivity rate of 97% (37/38)
with a sensitivity of 95% for detection using plasmid
PCR, 90% by MOMP PCR and 95% by Hsp 60 real-
time PCR (Table 2). Of the QIAamp samples 90% (34/
38) amplified for each of the three PCRs as opposed to
71% (27/38) of the Proteinase K-Chelex samples and
only 50% (19/38) of the TE-Chelex samples (Table 2).
The plasmid primers were the most successful for the
amplification of C. trachomatis DNA extracted by each
of the three methods, followed by the Hsp 60 primer
set and then the MOMP primer set (Table 2).
Real-time LightCycler PCR analyses of C. trachomatis copy
numbers
Real-time quantitation of C. trachomatis copy numbers
in samples was carried out to determine if reduced
sensitivity of detection by PCR was associated with
low copy numbers of the organism and to determine
the relative yield of C. trachomatis copy numbers for
each extraction method.
Table 1. DNA oligonucleotides used for
polymerase chain reaction
Gene
target
Primer
name
Primer
sequence
Fragment
amplified (bp)
Plasmid CTP 1 5¢-TAGTAACTGCCACTTCATCA-3¢24 201
CTP 2 5¢-TTCCCCTTGTAATTCGTTGC-3¢
momp MOMP A 5¢-TATACAAAAATGGCTCTCTGCTT-3¢25 540
MOMP B 5¢-CCCATTTGGAATTCTTTATTCACATC-3¢
hsp60 Hsp 60 F 5¢-GATGGTGTTACCGTTGCGA-3¢26 650
Hsp 60 R 5¢- CCTCCACGAATTCTGTTCAC-3¢
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The QIAamp and the Proteinase K-Chelex samples
most commonly gave copy numbers of 104/ll of
extracted DNA as opposed to the TE-Chelex samples
which gave a lower yield of 102/ll of extracted DNA
(Table 2). The distribution of copy numbers was
evenly spread for the Proteinase K-Chelex samples,
when compared with the TE-Chelex and QIAamp
samples, which had copy numbers concentrated at the
lower and upper end of the range respectively
(Table 2).
Negative results by the plasmid and the MOMP
PCRs were frequently associated with low copy
numbers. Of the four TE-Chelex extracted samples
negative by plasmid PCR, three were below the
detection level of 100 copies of C. trachomatis/ll of
extracted DNA and of the 15 MOMP-negative samples
three samples had <1000 copies and 12 had <100
copies of C. trachomatis by quantitative PCR. Of the
four QIAamp samples which did not amplify for all
three genes, one sample was positive by Hsp 60 real-
time PCR only, with a copy number of 102. The other
two amplified for the plasmid but not the momp gene;
the real-time PCR result was negative for one and
copy numbers <100/ll DNA for the other).
Discussion
The advent of liquid-based cervical cytology may
enable gynaecologists to screen for both cervical
preneoplastic lesions and sexually transmitted infec-
tious agents from the same sample. This is based on
the ability of liquid-fixed cells to yield nucleic acids
suitable for molecular-based assays.27,28 There are a
growing number of publications using PreservCyt
specimens for molecular detection of organisms inclu-
ding HPV, herpes simplex viruses, Trichomonas vaginalis
and C. trachomatis.29,30 As DNA extracted from Pre-
servCyt specimens may be used to screen for multiple
organisms there is a need for the development of
simple rapid inexpensive DNA extraction methods,
M - 1 2 3 4
M - 1 2 3 4
M - 1 2 3 4
(a)
(b)
(c)
201 bp
540 bp
650 bp
Figure 1. (a) Examples of PCR amplification of a region of
Chlamydia trachomatis plasmid (201 bp) using the CTP primer
set. (b) Examples of PCR amplification of C. trachomatis major
outer membrane protein gene (540 bp) using the MOMP
primer set. (c) Examples of PCR amplification of the C.
trachomatis heat-shock protein 60 gene (650 bp) using the
Hsp 60 primer set. M ¼ 100 bp DNA marker; -: negative
control; 1: positive control; 2–4: different samples.
Table 2. Comparison of positive PCR results for each extra-
ction method using the CTP, MOMP and Hsp 60 primers,
with quantification of Chlamydia trachomatis copy numbers
by Hsp 60 real-time PCR
Primer set
No. of positive tests*
TE-Chelex (%) PK-Chelex (%) QiAmp (%)§
CTP 34 (90) 35 (92) 36 (95)
MOMP 23 (61) 28 (74) 34 (90)
Hsp 60 28 (74) 32 (84) 36 (95)
Chlamydial
copy/ll No of positive tests in each copy number level
<100 5 5 2
102 14 6 8
103 6 6 11
104 2 8 13
105 1 6 2
106 0 1 0
*All samples in the study were C. trachomatis positive by the
LCx assay.
Boiling in Tris-EDTA buffer followed by Chelex purification.
Proteinase K digestion followed by Chelex purification.
§QIAamp DNA extraction kit.
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which can readily be applied in the diagnostic setting.
The main aim of this study therefore was to compare
the efficiency of two inexpensive in-house DNA
extraction procedures (Tris-EDTA-Chelex and Prote-
inase K-Chelex) and one kit-based method (QIAamp)
for the detection of C. trachomatis by PCR.
The results of this study indicate that the commer-
cial QIAamp extraction kit was the most successful
extraction method for amplification of the three
different target genes, but that the Proteinase
K-Chelex method had a similar success rate for
C. trachomatis amplification when the plasmid primers
were used. However, amplification of larger PCR
products was less successful from Proteinase K-Chelex
than with the commercial extraction kit which would
have implications for application of other molecular
methods, particularly restriction enzyme digestion for
restriction fragment length polymorphism analysis.
In this study there was 90%, 92% and 95%
sensitivity of C. trachomatis detection by plasmid PCR
amplification by TE-Chelex, Proteinase K-Chelex and
QIAamp respectively. Koumans et al. also analysed
PreservCyt samples for C. trachomatis detection using a
commercial extraction and detection system and
reported 97% sensitivity for C. trachomatis detection.11
On comparison of commercial DNA extraction kits
QIAamp has been reported as the most successful.31 In
this study amplification for the plasmid gene was the
most successful method for detection of C. trachomatis
and showed the greatest concordance for the three
extraction methods. Other studies have shown that
plasmid primers are more sensitive than MOMP
primers for the detection of C. trachomatis due to the
presence of multiple plasmids per organism.32,33
Some studies have reported lack of reproducibility
of C. trachomatis detection, even with commercial
systems, and recommend duplicate samples or the
application of two NAAT detection methods.34 In this
study all samples were amplified for three different
genes to increase the specificity of detection. This
study recommends the combined use of the plasmid
and heat-shock protein 60 gene primers for PCR
detection of C. trachomatis.
Real-time PCR is a fast and effective way for the
detection and quantitation35 of bacterial load in
clinical samples and for validation of DNA extraction
methods. Real-time PCR quantitation was used in this
study to show that a drop off in sensitivity of
detection, particularly for the larger PCR products,
was associated with low copy numbers of C. tracho-
matis.
This study shows that a single PreservCyt cervical
specimen can be used as a source of high quality DNA
for testing for sexually transmitted infections. Opti-
mization of the method of DNA extraction from
PreservCyt is essential to avoid false negatives and
ensure adequate sensitivity of detection. Careful
selection of genes to be amplified and the PCR product
size for the detection of C. trachomatis is recommended.
Real-time PCR quantitation is a valuable method for
validation of the sensitivity of PCR detection methods.
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